Shares of Versigent (NYSE:VGNT - Get Free Report) passed above its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $42.65 and traded as high as $43.37. Versigent shares last traded at $42.9130, with a volume of 628,456 shares.
Analyst Upgrades and Downgrades
A number of analysts have commented on the stock. BNP Paribas Exane reaffirmed an "outperform" rating and set a $54.00 target price (down from $55.00) on shares of Versigent in a report on Thursday, November 5th. Wells Fargo & Company upped their price target on Versigent from $48.00 to $56.00 and gave the stock an "overweight" rating in a research note on Wednesday, August 5th. Fox Advisors cut Versigent from an "overweight" rating to an "equal weight" rating in a report on Wednesday, August 5th. Royal Bank Of Canada lowered their price objective on shares of Versigent from $53.00 to $52.00 and set an "outperform" rating for the company in a research report on Thursday, November 5th. Finally, Evercore reiterated an "outperform" rating and issued a $65.00 target price on shares of Versigent in a report on Monday, August 10th. Eleven equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $55.08.
Get Our Latest Report on VGNT
Versigent Stock Performance
The business's 50-day moving average price is $43.82 and its 200-day moving average price is $42.65. The company has a current ratio of 1.43, a quick ratio of 1.11 and a debt-to-equity ratio of 5.69. The stock has a market cap of $3.04 billion and a PE ratio of 11.20.
Versigent (NYSE:VGNT - Get Free Report) last issued its quarterly earnings results on Wednesday, November 4th. The company reported $1.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.79 by $0.12. Versigent had a net margin of 5.47% and a return on equity of 88.25%. The business had revenue of $2.45 billion for the quarter, compared to analyst estimates of $2.42 billion. As a group, equities research analysts expect that Versigent will post 7.40 earnings per share for the current fiscal year.
Versigent Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 17th. Stockholders of record on Friday, December 4th will be given a dividend of $0.13 per share. The ex-dividend date is Friday, December 4th. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.2%.
Insider Buying and Selling at Versigent
In other news, Director Kevin Clark sold 74,130 shares of the company's stock in a transaction that occurred on Wednesday, September 9th. The stock was sold at an average price of $45.67, for a total transaction of $3,385,517.10. Following the completion of the transaction, the director directly owned 124,849 shares of the company's stock, valued at $5,701,853.83. This represents a 37.26% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Over the last three months, insiders sold 220,000 shares of company stock worth $10,065,848.
Institutional Investors Weigh In On Versigent
Several institutional investors have recently bought and sold shares of the company. Wellington Management Group LLP purchased a new position in Versigent in the 2nd quarter worth approximately $940,000. Raiffeisen Bank International AG purchased a new position in Versigent in the second quarter valued at $1,182,000. HBK Investments L P purchased a new stake in shares of Versigent during the second quarter worth approximately $14,439,000. Steamboat Capital Partners LLC purchased a new stake in Versigent during the 2nd quarter worth about $10,385,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in shares of Versigent in the 2nd quarter valued at $2,417,000.
Versigent Company Profile
(
Get Free Report)
Versigent PLC is involved in the design, manufacturing and delivery of low and high voltage power electrical architectures. Versigent PLC is based in SCHAFFHAUSEN, Switzerland.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Versigent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Versigent wasn't on the list.
While Versigent currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.